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Highlights 
• This systematic review analysed Chronic Care Models for cardiovascular diseases. 
• Most studies reported outcome improvements and patient compliance with treatment. 
• Some studies demonstrated reduction of medical burden, like healthcare utilization. 
• They are effective to reduce risk of heart failure & other cardiovascular diseases. 
• They are restricted by academic robustness and social constraints in primary care. 
 
 
Abstract 
Background: Chronic Care Model (CCM) has been developed to improve patients' health care by 
restructuring health systems in a multidimensional manner. This systematic review aims to 
summarize and analyse programs specifically designed and conducted for the fulfilment of multiple 
CCM components. We have focused on programs targeting diabetes mellitus, hypertension and 
cardiovascular disease. 
Method and results: This review was based on a comprehensive literature search of articles in the 
PubMed database that reported clinical outcomes. We included a total of 25 eligible articles. 
Evidence of improvement in medical outcomes and the compliance of patients with medical 
treatment were reported in 18 and 14 studies, respectively. Two studies demonstrated a reduction of 
the medical burden in terms of health service utilization, and another two studies reported the 
effectiveness of the programs in reducing the risk of heart failure and other cardiovascular diseases. 
However, CCMs were still restricted by limited academic robustness and social constraints when 
they were implemented in primary care. Higher professional recognition, tighter system 
collaborations and increased financial support may be necessary to overcome the limitations of, and 
barriers to CCM implementation. 
Conclusion: This review has identified the benefits of implementing CCM, and recommended 
suggestions for the future development of CCM. 
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Introduction 
Worldwide, chronic disease remains a significant burden in terms of morbidity and mortality. 
Diabetes mellitus (DM), hypertension (HT), cardiovascular disease (CVD) and chronic obstructive 
pulmonary disease (COPD) are four major chronic disease states with a high prevalence in 
populations around the world. The incidence of these four diseases has increased rapidly in recent 
decades [1–9]. Historical models of clinical care, largely developed for acute illness management, 
are proving less able to meet the complicated needs of the increasing burden of chronic care 
[10,11]. As a result, ineffective therapy and suboptimal disease control could lead to patient 
dissatisfaction [11]. Escalating healthcare demands have led to a substantial increase in medical 
burden, including avoidable hospital admissions and unnecessary healthcare expenditure [12,13]. 
 
Chronic Care Model (CCM), one of the widely recognized disease models in the world [14], was 
proposed by Wagner et al. in the 1990s [10]. It served as a patient-centred, evidence-based, 
proactive framework that aims to redesign ambulatory care systems and achieve health care 
improvement for patients suffering from chronic disease [10,14–16]. CCM consists of six key 
components, including health system or a health organization (HSHO), clinical information systems 
(CIS), decision support (DS), delivery system design (DSD), self-management support (SMS) and 
community-including organizations and resources for patients (CORP) [10,14,17]. Wagner [10] 
advised that the interactions between patients and healthcare providers should consist of well-
developed processes and incentives that allow changes in the care delivery system. Additionally, 
these CCMs could give behaviourally complicated self-management support that offers priority to 
enhancing patients' confidence and skills, so that patients can be the ultimate manager of their own 
illnesses. Also as Wagner defined [10], the CCMs could “reorganize team function and practice 
systems; develop and implement evidence-based guidelines and support those guidelines through 
provider education, reminders, and increased interaction between generalists and specialists; as well 
as enhance information systems to facilitate the development of disease registries, tracking system, 
and reminders and to give feedback on performance.” 
 
So far, CCM has been adopted and implemented in many areas of medical practice [10,12,18–24]. 
The results of these studies have suggested that implementation of CCM could greatly improve 
medical outcomes and reduce unnecessary medical burden. Strategies for preventing avoidable 
hospitalizations suggested by articles in the literature are strongly connected with CCM 
components, such as self-management training for both patients and healthcare providers 
[12,21,22,25,26], identification of existing community resources [12,27,28], electronic systems of 
medical records for monitoring, as well as sharing and linking among ambulatory services, hospitals 
and communities, and primary care practices [12,13,29]. Moreover, healthcare providers have 
shown good adherence to the medical practices which were tailored and multifaceted with CCM 
components [30]. Nevertheless, no single component within CCM may achieve all these expected 
goals, indicating that adopting multiple components of CCMs is essential to enhancing quality 
health in primary care [10–12,14–16,19,31–34]. 
 
This review aims to summarize and analyse the primary care programs specifically designed and 
conducted for patient care that comprise various CCM components. The papers reviewed here 
present a clear view of the current development of CCM implementation in primary care. The 
medical and social benefits to patients and healthcare providers, as well as present limitations in the 
system have been systematically analysed and discussed. The objective of this review is to identify 
the benefits and limitations of CCM so as to inform future optimization of CCM for chronic disease 
care. 
 
 
Methods 
The present systematic review included models of chronic disease care, including diabetes, 
hypertension, cardiovascular disease and chronic obstructive pulmonary disease. Since both 
PubMed and EMBase cover the literature of Medline and PubMed alone has the features of easy 
keyword searching and automatic mapping to MeSH terms without the need of subheading 
selection, we chose PubMed as convenient and applicable for our use. Thus, the search was 
performed in the PubMed database from its inception (literature covered back to 1966) to June 2016 
by using the following strategies: 
 
1. Model*[Text Word] AND chronic care [Text Word] (1050 articles identified) 
2. Limit 1 to “Humans” (824 articles identified) 
3. Limit 2 to “English” (789 articles identified) 
4. Limit 3 to “full text” (702 articles identified) 
5. Limit 4 to each of following sub-theme by combining with the search terms shown in strategy 1 
 
a.    Diabetes[Text Word] 
b.    Hypertension[Text Word] 
c.    Cardiovascular disease[Text Word] 
d.    Chronic obstructive pulmonary disease[Text Word] 
 
The articles included were those that described models providing proactive care for patients with 
diabetes, cardiovascular disease, hypertension and/or chronic obstructive pulmonary disease. The 
papers identified focused on clinical perspectives of the models, defined as the direct observation of 
patients or the viewpoint of health professionals, such as doctors and nurses who worked directly 
with patients. Articles were excluded if they were duplicate, or did not involve any observation on 
patients. Meta-analyses, reviews, protocols and commentaries were also excluded. An extensive 
literature search and careful screening of the potentially eligible studies included in this literature 
review were performed by two independent reviewers, and any disagreement was resolved by a 
third reviewer. Supplementary Fig. 1 shows the algorithms by which the articles were included. 
 
 
Results 
A total of 702 journal articles were retrieved based on the first three steps of the search strategy. Of 
these articles, 308 were obtained under the four disease categories. After reviewing the titles and 
abstracts, 278 were excluded. Five duplicates were removed, resulting in a total of 25 articles being 
included in the present review (Table 1). All these reviews were related to four chronic medical 
conditions (i.e., diabetes mellitus, hypertension, cardiovascular disease and chronic obstructive 
pulmonary disease). 
 
1. Diabetes Mellitus 
Among all the 25 selected articles, 23 were published in the period 2002–2015 on patients suffering 
from diabetes as the primary study focus. They demonstrated the impact of CCM on primary care 
(Table 1). One of these articles by Bodenheimer et al. [17] summarized three CCM-introduced 
programs in diabetes patients. Hence, there were 25 individual studies included in this review. 
Based on the information provided in the articles, the majority of the enrolled programs (19/25) 
were led by professional healthcare providers (i.e., physicians, physician/medical assistants, 
residents, primary care clinicians, registered nurses, nurse assistants, and health workers) in at least 
one hospital or primary care centre. The number of participating patients varied from 68 to 553,556 
due to the different scales among the included studies. Most programs recruited older patients as 
subjects and one-third of these studies focused on type 2 diabetes patients. One of the programs 
included patients with cardiovascular diseases as a comorbidity. Different types of intervention-
related studies were used to investigate the impact of CCM implementation. The follow-up period 
varied between 3 months and 4 years. 
 
A total of 19 enrolled programs (Table 2) reported clinical outcomes that illustrated the impact of 
CCM implementation on disease optimization. There were several important medical indicators 
measured in these programs, including HbA1c (Glycated Haemoglobin), blood pressure (in 
particular systolic blood pressure, SBP), blood lipid levels (e.g. low-density lipoprotein 
cholesterol), body mass index (or weight), foot examination and periodic eye examination. These 
data were reported by two different methods: the proportion of patients who reached optimal 
clinical targets (e.g. HbA1c ≤ 7%, BP ≤ 130/80 mmHg or LDL < 100 mg/dl) and the average 
value of the clinical indicators. Based on a pooled analysis, the proportions of patients reaching the 
targets in HbA1c, blood pressure and blood lipids in the intervention group were 1.8–28%, 3.8–
45% and 3.2–58%, respectively, which were higher than those in the respective control groups. 
Among them, three programs found significant differences in the improvement of HbA1c, and two 
programs reported improvement of blood pressure and blood lipids, respectively. Similar significant 
improvements in these clinical parameters were found when the average values of the intervention 
and control groups were compared. 
 
In addition, the implementation of CCM was found to bring benefits in patient compliance with 
therapy, promotion of health behaviour, satisfaction with clinical care, and reductions in the medical 
burden (Table 3). Data from intervention groups showed an average of 15% improvement in the 
rate of measuring HbA1c, blood pressure and blood lipids. Also, more obvious improvements were 
observed in terms of health behaviours (compared with control groups, additional improvement in 
intervention groups 5.6–85%, average ~ 30%), including the rate of BMI measurement, smoking 
status assessment, foot examination, eye examination and self-management plans formulated by 
healthcare professionals. In six of these programs, both Assessment of Chronic Illness Care (ACIC) 
score and Patient Assessment of Chronic Illness Care (PACIC) score increased, indicating that 
patients were more satisfied with CCM implementation compared to usual care. Furthermore, there 
were two programs that reported the cost-saving aspects of the CCMs. Stock [35] indicated that the 
Germany Program saved 446.75 USD in the overall cost of illness care per insured patient during 
2003 to 2007 and shortened the hospitalization duration per insured patient by 1.44 days. Siminerio 
[22] reported an 80,000 USD increase in net revenue of “Diabetes Self-Management Training” 
reimbursement and educators' salary from Jan 2002 to Jun 2004. On the other hand, Vargas [36] 
measured the 10-year cardiovascular risk for the diabetes patients and found a reduced risk at 2.1% 
in the group that received interventions under CCM. 
 
2. Hypertension (HT), Cardiovascular Disease (CVD) and Chronic obstructive pulmonary 
disease (COPD) 
Among the 25 enrolled programs, there were three programs focusing on HT, four programs on 
CVD and one program on COPD. Stroebel [37] and Chen [38] included hypertensive patients, 
whereas Turner [39] conducted a single blinded RCT among African-American patients with 
uncontrolled hypertension. Caruso [40] recruited patients with CVD only and patients with CVD 
and DM as a comorbidity; Vargas [36] studied the impact of CCM implementation on reducing 10-
year CVD risk among DM patients; Lalonde [41] carried out a one-day workshop (six focus groups) 
for CVD-risk patients, family members, physicians, other professionals, decision makers and 
researchers, in which the opinions on CCM implementation were discussed. Mirzaei [42] performed 
a focus group study among 52 COPD/CHF/DM patients, 14 patients' care-givers and 63 health care 
professionals with respect to their concerns and suggestions on CCM. 
 
Among these studies, there are six programs with a number of participating patients ranging from 
109 to 1,170 [36–40]. After 6 months to one year, the outcomes obtained from the follow-up of 
these programs showed that the proportion of patients who reached clinical targets greatly 
increased. In particular, individuals in the CCM intervention group (Turner et al., [39]) had greater 
reductions in the average systolic or diastolic blood pressure values. Other medical outcomes 
showed similar findings. 
 
Furthermore, two qualitative studies reported the opinions of healthcare providers and patients in 
more depth. In Mirzaei [42], patients, their care-givers and health care professionals discussed the 
challenges, suggestions and solutions regarding [1] communication and delivery of information; [2] 
organization of service delivery and waiting time to see HCPs; and [3] facilitation of self-care, 
focus on a single illness, and inclusion of patients and their care-givers in decision making. Lalonde 
[41] suggested eight proposals for relevant CCM components, and the top three priorities included 
the desirable need of “a computerised platform assessable to all health providers”, “a 
multidisciplinary team”, and “a case management nurse position.” 
 
3. CCM components 
Generally, the implementation of Chronic Care Model had made significant improvements in 
primary care. All the enrolled programs contained at least three components of CCM (six 
components in total), as shown in Table 4. The CCM components have been adopted in ~ 76% of 
enrolled programs on average. Among the six components, Self-Management Support is the most 
popular (96.3%) and Community including Organizations and Resources for Patients (CORP) is the 
least popular (40.7%). These programs consist of a variety of components that were designed 
according to the requirements of the CCM components [10] (Table 1): (a) Team building, health 
provider group meeting and feedback were the most frequently conducted activities according to the 
concept of “Health System or a Health Organization” (HSHO) component; (b) Electronic record or 
registry was required by “Clinical Information Systems” component (CIS); (c) Provider education, 
guideline or protocol development and distribution were typical activities involved for “Decision 
Support” (DS) component; (d) Electronic alert or phone call reminder to physician or patients, visits 
in follow up, and scheduled appointments or meetings were widely held for “delivery system 
design” (DSD) component; (e) Patient education and self-management/care plan helped in patient 
motivation and behaviour change, which were to achieve the objective of “Self-management 
Support” (SMS) component; and (f) Specialists or expert participation, and community clinician 
involvement were used to strengthen the “Community including Organizations and Resources for 
Patients” (CORP) component. 
 
4. Unique contributions of CCM components to patient care 
The “Health System or a Health Organization” (HSHO) component 
The functions of HSHO and its connections with other health service providers form the basis of the 
rest of the Chronic Care Model components [17]. The environment of a HSHO, ranging from local 
policies of the community to national policies of the government, exerts a great influence on 
chronic care management [31]. HSHO of health care could be enhanced to reward quality and 
sustain the improvements of chronic care by featuring innovation and favourable funding [41] The 
introduction of innovative leader to HSHO could also incentivise chronic care planning [47]. 
 
The “Clinical Information Systems” (CIS) component 
CIS tracks patients seeking chronic care at different levels: from primary to secondary and tertiary 
[31]. It contributes to patient care in three ways, 1) by acting as a registry system for managing 
health service of a population; 2) by providing reminders that keep primary care physicians (PCP) 
in compliance with clinical guidelines; and 3) by providing feedback to control quality of care [17]. 
Registry produces database that offers longitudinal information at an individual level and its 
establishment enable patient outreach and visits planning [43,20]. Sharing electronic medical 
records (EMRs) also facilitate inter-professional and inter-institutional communication for patient 
care [40]. 
 
The “Decision Support” (DS) component 
DS for PCPs includes education and training as required to enable enhanced communication and 
counselling skills among PCPs; their compliance with guidelines; as well as quality control and 
surveillance of health service [31]. Evidence-based guideline is an important decision-support 
modality that provides recommendations, on which PCPs feedback information and reminder 
systems of CIS are based [17]. Involvement of specialists in primary care is another decision-
support tool. In planning specialist referrals, PCPs could decide conventional referrals or simply a 
phone consultation that does not always need conventional referral [20]. 
 
The “delivery system design” (DSD) component 
An important way to promote DSD is to strengthen roles of manpower in delivering primary care, 
and to enable referral to specialist for consultation and treatment where appropriate [47]. Primary 
care centres with sufficient PCPs, active specialists, and follow-ups for patients provide more 
opportunity for health management and contribute to better chronic disease control [31]. A 
multidisciplinary health centre characterised with availability of inter-professional collaboration 
would also benefit patients in maintaining their continuity of care [41]. 
 
The “Self-management Support” (SMS) component 
SMS, based on patient empowerment, is a key function of the Chronic Care Models [17]. It is 
developed and supported by education, counselling, and training of patients with non-
communicable disease and their families with lifelong follow-up and self-assessment of care [43]. 
Patients with relevant knowledge and skills are able to manage the chronic conditions by 
themselves. Besides, several studies show that SMS can contribute to improved clinical outcomes, 
better quality of life, and decreased costs [49]. Development of SMS requires both patients and the 
health providers to share responsibility for continuous improvement of patient care [44]. 
 
The “Community including Organizations and Resources for Patients” (CORP) component 
CORP involves proper allocation of available community resources and promotion of national and 
local governmental policies to create a chronic disease care-friendly environment [31]. To promote 
high quality chronic care, health providers need linkages with community-based resources which 
are especially useful for small care centres with insufficient resources [17,24]. Community 
resources may help patients acquire self-management skills, such as achieving lifestyle 
modifications that positively influence chronic disease control [40]. It could be incorporated in daily 
clinical consultations as easy-to-access resources that meet patient needs [41]. 
 
 
Acknowledged limitations 
Except the three case studies reported by Bodenheimer in 2002, the majority of the literature 
acknowledged several limitations in their programs. These include weaknesses in study designs, 
data contamination and constraints, biases caused by selection and system, problems associated 
with differing characteristics of patients and professional providers, methodological issues of 
intervention and follow-up, as well as pressures induced by budgetary constraints. Because CCM 
implementation played a very important role in the selection of patients and intervention of the 
enrolled programs, more concerns were raised than other program terms, which made these two the 
most frequently mentioned limitations (11/25 and 12/25, respectively) in the analysis. Data 
contamination and follow-up issues are the least frequently reported limitations (both at 4/25) 
among the analysed programs. The literature also mentioned that professional providers (e.g. health 
coaches, centres and residents) are the most significant source of contamination. Other limitations 
of these CCM were mentioned in 5/25 to 9/25 of the programs. 
 
 
Discussion 
Diabetes mellitus, hypertension, cardiovascular disease and chronic obstructive pulmonary disease 
are four major chronic diseases in terms of medical burden on a global scale. A close relationship 
among these four major chronic diseases is well recognized; and high blood sugar, plasma lipid and 
uncontrolled blood pressure levels are common clinical indicators. These chronic diseases are 
significantly associated with unhealthy lifestyles (e.g. dietary intake of high-glucose/fat, lack of 
physical activities, tobacco use or alcohol consumption). Thus far, attempts to design and 
implement CCMs have been realized in primary care programs for several decades. As shown in 
Supplementary Fig. 2 and Table 1, six CCM components operate and interact in a multidimensional 
manner [37,39,43,44]. Increasing the number of CCM dimensions has been shown to produce more 
benefits to patients and healthcare providers, considering [1] patients may receive improved 
medical outcomes, more knowledge about disease management and enhanced health awareness; [2] 
health professionals may obtain training in working in the teams comprised of multiple types of co-
workers; and [3] social medical burden may be reduced due to effective disease management and 
reduced disease risk in the population. 
 
There were also several limitations and barriers to CCM implementation in the included studies, 
such as the robustness of academic evaluation and societal factors (Supplementary Fig. 2, Table 4). 
Among all the studies included in this review, six programs stated the absence of blinding or 
randomization [20,35,37,40,43,44]; four programs reported that the follow-up period was too short 
for the adequate detection of significant outcomes [24,38,45,46]; whilst three programs had a 
relatively small sample size [21,28,47]. Selection bias in patient recruitment includes differences in 
illness status [35], racial and cultural diversity [36,37,48], as well as in socioeconomic status [35]. 
As a result, the study findings might not be generalizable to other population groups [42]. In 
addition, non-medical practical issues also play an important role in CCM implementation. Most of 
the programmes were based on efforts made by volunteering healthcare providers. Therefore, some 
healthcare professionals might not join the programme or simply drop out, and in some programmes 
the relevant stakeholders might have lower motivation [36,39]. Sunaert et al. [24] mentioned that 
some physicians expressed their fear of losing patients and practice income because they thought 
that the primary care programmes could not receive enough attention and might not be appropriate 
for certain patients. Working in relatively isolated environments with lack of support in practice has 
been recognized as a barrier, especially in primary care systems that were not efficiently organised 
[24]. There are various social determinants of health and a CCM might not be able to address all 
components especially in populations with different patient groups. Hence, for CCM to function 
optimally, policy-makers will need to take into account various factors related to system design, 
including different socioeconomic factors, accessibility to healthcare, and the technology available. 
Moreover, it is occasionally difficult to motivate patients when consultation times are limited [24]. 
Furthermore, implementation of CCM in the community requires multidisciplinary team 
collaboration in an organized, concerted manner, and this might not be easily achievable in 
countries where primary care is still developing. Finally, existing studies have not demonstrated that 
CCM could account for all the beneficial effects per se, since patients are treated and managed in an 
individualized manner. 
 
Thus far, there are several studies examining CCM using different perspectives, such as a 
comparison of CCM with other primary care models [14], perceptions of CCM implementation 
among relevant stakeholders in primary care settings [33], or CCM implementation in a certain 
disease management [11,23]. However, there exist knowledge gaps regarding the consistent benefits 
and limitations during CCM implementation in different programs/interventions reported by the 
existing literature. The strength of this review includes its comprehensiveness in extracting the 
important constructs of CCM, offering deeper insights into CCM implementation contextualized to 
the current medical system, and delivering important message to policy makers or stakeholders for 
future improvement of chronic disease management. 
 
 
Unique contributions of CCM components to patient care 
Among the included studies of this review, some (8/25; 32%) have attempted to separately 
investigate individual components of CCM while others implemented the entire CCM as a 
multifaceted intervention. The results gave us an overall impression that CIS, DSD, and SMS were 
priorities when implementing CCM in the primary care settings. 
 
Deviation in CCM practice scores across sites was identified for CIS and HSHO in a study [50]. 
Variation of the implementation improvements was also found for different components by using 
Assessment of Chronic Illness Care survey (ACIC). Sunaert et al. discovered in their program the 
scores of all components increased with those for DSD and CIS changed the least [24]. Although 
their project was then expanded, it had only a limited impact on the CCM at the primary care level 
(DSD) and the use of CIS in practice. Another study had similar findings that the sub-scales except 
for DSD demonstrated significant improvements in post-implementation ratings [31]. However, the 
program led by Frei et al. found statistically significant differences in changes over time between 
intervention and control group patients in all CCM components, yet did not find statistically 
significant differences in changes between different components over time [45]. 
 
Additionally, there was variation in the use of components with better results. Yu et al. identified 
two interventions, the registry in CIS and patient skills in SMS, had the greatest influence on 
improving incorporation of the CCM [47]. Musacchio et al. concluded the DSD and SMS were 
systematically associated with better process and outcome measures [49], whereas another study by 
Lalonde et al. regarded CIS and DSD as the priorities selected for prevention in Primary care [41]. 
 
Although these studies tried to explain the results in relation to the various CCM components, 
evaluation of CCM is challenging given the fact that these components may act both independently 
and interdependently. Within a program, variation in CCM practice scores for each component 
across sites may result in that performance cannot be meaningfully compared between practices. 
The decentralized operating units may have also caused variability in the way domains of the CCM 
are implemented and in the relative emphasis on each domain. Implementation varies between study 
sites and for individual domains within sites; as a result, local population care programs differ 
across the system. However, given the relatively low marginal cost per patient of providing the 
entire collection of services, the effectiveness of individual CCM components might not be of 
substantial significance. 
 
 
Limitations 
Some limitations of this review should be addressed. The literature was retrieved based on search 
strategies in PubMed, by which only the references that specifically mention Chronic Care Models 
were included for discussion. Therefore, the number of the studies that could be reviewed might be 
limited. Studies that were published in language other than English were not included, and there 
might be a certain number of articles published in the grey literature. Besides, these studies have 
been mainly conducted in the developed countries. The conclusion may not be generalizable to 
other regions due to the variation in age, income, access to care, available technology and other 
social and demographic characteristics. Especially for developing countries experiencing an 
epidemiological transition, Chronic Care Models need to be further examined in future studies. 
 
 
Conclusions 
According to the present systematic review, the implementation of CCM in primary care can 
substantially improve medical outcomes, enhance patients' quality of life, and decompress social 
burden in a multidimensional manner. Nevertheless, there are some limitations of CCM that might 
need to be carefully scrutinized, such as health professionals working in isolation, who may have 
low motivation, economic concerns and insufficient knowledge; patients who are difficult to 
motivate; errors and omissions present in clinical information systems; as well as limits of linking 
with the community etc. These implied that greater collaborative efforts from various stakeholders 
in the society and additional financial support may be required. Further optimization and integrative 
applications of the six CCM components, as well as the empowerment of their interactions, may 
bring benefits to the health care system. 
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Table 1. Characteristics of studies included in the present review 
Author Publish 
year 
Study design Patients types* No. of Professional Facilities No. of 
participating 
patients 
Mean age [years] (male %) Follow-up 
(years) Hospital or Primary 
Care Center 
Physician or Related Nurse or Technician or 
Related 
Intervention Control 
Page et al. [44] 2015 
Pre- and post- intervention 
study 
DM NA NA NA 5539 50-59 (45.94a) 50-60 (NA) 1 
Ku et al. [31] 2015 
Pre- and post- intervention 
study 
T2 NA NA NA 164 56.76a (25.6) NA (NA) 1.83 
Frei et al. [45] 2014 CCT T2 NA 30 NA 328 50 (54) 51.5 (60) 1 
Hariharan et al. [20] 2014 non-RCT DM 1 
11 physician 
32 residents 
6 medical assistants 
4 1674 57.8 (39.3) 57 (43.8) 1 
Mirzaei et al. [42] 2013 Qualitative study DM, CHF, COPD 2 63 residents NA 52 45-85 (53.8) NA (NA) NA 
Turner et al. [39] 2012 Single-blinded RCT Uncontrolled HT 2 A peer and practice team team 280 61.2 (30) 62.6 (39) 0.5 
Lalonde et al. [41] 2012 Qualitative study Potential CVD NA 6 physicians 6 nurses 6 patients NA NA 1-day 
     
6 pharmacists 
6 other health professionals 
6 health administrators 
6 researchers 
6 family 
members 
  workshop 
Musacchio et al. [49] 2011 Pre- and post-intervention study T2 1 NA NA 1004 66.6 (54.1) NA (NA) 0.5-2 
Chen et al. [38] 2010 non-RCT T2 and HT 1 13 year-one residents 11 healthy workers 541 62.4 (37) 60.3 (36) 1 
Barceló et al. [18] 2010 CCT DM 10 43 teams  307 40-59b (NA) 40-59b (NA) 1.5 
Yu et al. [47] 2010 
Pre- and post- intervention 
study 
DM University-based 
6 residents 
2 faculty clinician or staff 
NA Small Size NA (NA) NA (NA) 1 
Frølich et al. [50] 2010 
Cross-sectional & stepwise 
regression 
DM 41 NA NA 553556 50 to >65b (51) NA (NA) NA 
Khan et al. [46] 2010 Prospective single cohort study DM 1 NA NA 1098 51 (59) NA (NA) 0.16–1 
Sunaert et al. [51] 2010 Region-RCT T2 41 83 90 4174 41.32 (47.13) 
40.63 
(44.31) 
4 
Stock et al [35]. 2010 Pre- and post-intervention study T2 NA NA NA 91696 NA (44.93) NA (NA) 4 
Sunaert et al. [24] 2009 Pre- and post-intervention study T2 41 83 90 2300 NA (NA) NA (NA) 4 
DiPiero et al. [43] 2008 Retrospective cohort DM 1 
25 faculty members, 46 
medical residents 
 565 58.9 (39) 58.3 (44) 0.5–2 
Caruso et al. [40]c 2007 
Pre- and post- intervention 
study 
T2, CVD and T2 
+CVD 
1 NA NA 283 
73.7 (32), 76.3 
(37), 73.6 (30) 
76 (36) 1 
Vargas et al. [36] 2007 
Controlled pre- and post- 
intervention study 
CVD risk in DM 
patients 
13 13 91 1170 64 (64) 65 (59) 1 
Piatt et al. [28] 2006 Multiple-CCT DM 11 21 3 68 69.7 (50) 68.6 (58.8) 1 
Siminerio et al. [22] 2006 Pre- and post-intervention study DM 166 1400 NA 31150 NA (NA) NA (NA) 4 
Siminerio et al. [21] 2005 non-RCT T2 1 
4 physician 
1 physician assistant 
3 registered nurses 
2 technicians 
1 nurse assistant 
104 67 (64.7) 65.4 (42.5) 1 
Stroebel et al. [37] 2004 
Pre- and post- intervention 
study 
DM, HT and HL 1 6 providers 2 109 NA (NA) NA (NA) 1 
MacLean et al. [48] 2004 Baseline of a CCT DM 
10 hospitals 
55 primary care centers 
121 medical providers  
7345 >18 (NA) NA (NA) NA 
Bodenheimer et al 
[17] 
2002 
Pre- and post- intervention 
study 
DM 36 private ofﬁce 
100 NA 
NA NA (NA) NA (NA) NA 
  Pre- and post- intervention 
study 
DM 18 
NA NA 
6542–7037 NA (NA) NA (NA) 1 
  Pre- and post- intervention 
study 
DM NA 
NA NA 
NA NA (NA) NA (NA) 2 
 
*Type: DM: diabetes mellitus; T2: type 2 diabetes mellitus; CHF: chronic heart failure; HF: heart failure; AT: arthritis, HT: hypertension; CVD: cardiovascular disease; HL: High Lipid. 
a Number was calculated based on the information reported.  
b Range of age is represented for the largest population in the study. 
c This study included patients with T2 only, CVD only and T2+CVD, thus the data was listed in the same sequence.
Table 2. Clinical outcomes of the enrolled programs 
 
 
Author (published year) Program name HbA1cb 
 
Blood pressure (SBP) Blood lipid BMI (or 
weight) 
Foot exam Eye exam 
  Difference of 
change (%)a 
Mean change 
of value (%) 
Difference of 
change (%)a 
Mean change of 
value (mm g) 
Difference of 
change (%)a 
Mean change 
of value 
Specificd Mean change 
of value 
Difference of 
change (%)a 
Difference of 
change (%)a 
Ku (2015) [31] FiLDCare 
 
− 0.8 
        
Frei (2014) [45] CARAT 
 
+ 0.1 
 
− 3.6 
 
-0.2 LDL 
(mmol/L) 
− 0.4 
  
Hariharan (2014) [20] DITTO 
 
− 0.37 
        
Turner (2012) [39] / 
   
− 7.92 
      
Musacchio (2011) [49] SINERGIA + 13.0 
 
− 1.2 
 
+ 7.6 
 
LDL 
   
Chen (2010) [38] Teamlet + 1.8 
 
+ 3.8 
 
+ 3.2 
 
LDL 
   
Barceló (2010) [18] VIDA + 4.5 
 
+ 4.9 
 
+ 6.9 
 
C 
 
+ 71.6 + 61.8⁎ 
Yu (2010) [47] SJOFMRP + 5.5 
 
+ 22 
 
+ 10 
 
LDL 
   
Khan (2010) [46] / 
 
− 1.5 
 
− 9 
 
− 16 LDL 
(mmol/L) 
(− 2.3 lb) 
  
Sunaert (2010) [51] BE 
 
+ 0.06 
   
− 6.29 TC (mg/dl) 
  
DiPiero (2008) [43] CIM + 17.5 
 
+ 10 
 
− 1 
 
LDL 
   
Caruso (2007) [40]e GAP 
 
-0.6, NA, − 0.6 
  
− 12.5, 
− 12.7, − 14.2 
LDL (mg/dl) 
  
Vargas (2007) [36] / 
 
− 0.24 
 
− 0.4 
 
− 0.01 Log TC 
   
Piatt (2006) [28] PTPROV 
 
− 0.7 
 
+ 2.7 
 
+ 11.8 non-HDL (mg/dl) 
  
Siminerio (2006) [22] DSMT 
 
− 0.45 
        
Siminerio (2005) [21] / + 15.4 
 
+ 38 
 
-30 
 
LDL 
   
Stroebel (2004) [37] / + 21 (n = 60)c + 45 (n = 89)c + 58 (n = 19)c LDL 
   
Bodenheimer (2002) [17] PHP + 28 
       
Similar as HbA1c 
 
HPMG + 7.8 
   
+ 8.7 
 
LDL 
   
 
CC + 1.9 
         
 
a    Difference of change (%): Proportion change of the patient number reached medical goal in intervention group (baseline vs. follow-up) – proportion change of the patient number reached medical goal in control group (baseline vs. follow-up). 
b    HbA1c: glycated haemoglobin. 
c    Because of different types of patients, the numbers of patients who participated in the test are addressed in brackets. 
d    LDL: low-density lipoprotein; TC: total cholesterol; C: cholesterol; HDL: high-density lipoprotein. 
e    This study included patients with T2 only, CVD only and T2 patients with CVD, so the data was listed in the same sequence. 
⁎    Significant difference (P < 0.05). 
Table 3. Changes of measurement rates (%) in terms of clinical processes, chronic disease scores, financial issues and other terms 
 
Author (publish 
year) 
Program 
name 
Change of measurement rate % in clinical process (intervention group) Overall 
ACIC scorec 
Overall 
PACIC 
scored 
Financial issue Other terms 
HbA1c BP 
(SBP) 
LDL (or 
others)a 
BMI Smoking 
status 
assessed 
Foot 
exam 
Eye 
exam 
Self-
management 
plan made 
Value Specific Value Specific 
Page [44] FHQC + 2.4⁎⁎ 
 
− 0.1 
  
+ 10.9⁎
⁎ 
+ 5.6⁎
⁎ 
       
Ku [31] FiLDCare 
         
+ 0.3⁎⁎ 
    
Frei [45] CARAT 
         
+ 0.2 
  
No change SF-36 
Hariharan [20] DITTO 
     
+ 62 
        
Turner [39] / 
            
− 0.82%** Predicted 4-
year CHD risk 
Chen [38] Teamlet + 5.6 
 
− 5.8⁎⁎ + 85.
0⁎⁎ 
+ 82.8⁎⁎ 
  
+ 36.8** 
      
Barceló [18] VIDA 
   
− 0.3 
    
+ 3.0** 
     
Yu [47] SJOFMRP     + 9 
(cessation) 
+ 21 + 20 + 48 + 3.64      
Sunaert [51] BE + 3.71⁎⁎  + 3.39⁎⁎ 
(TC) 
     + 3.05      
Stock [35] GP 
     
+ 20.2 + 10.9 
   
− 446.75 
USD 
Overall cost 
differencee 
− 1.44 days Hospitalization 
per insured 
Sunaert [24] BE 
        
+ 3.05 
     
DiPiero [43] CIM + 1 + 26⁎
⁎ 
+ 9⁎⁎ 
  
+ 30⁎⁎ + 17⁎⁎ + 53⁎⁎ 
      
Caruso [40]b GAP + 19⁎⁎, 
NA, 
+ 14⁎⁎ 
 + 9⁎⁎, 
+ 3⁎⁎, 
+ 6⁎⁎ 
  + 31⁎⁎, 
NA, 
+ 32⁎⁎ 
        
Vargas [36] / 
            
− 2.1% Adj. UKPDS 
10-year risk 
Piatt [28] PTPROV 
            
+ 0.2 WHO-QWB10 
Siminerio [22] DSMT           + 80,000 
USD 
Net 
revenuef 
  
Siminerio [21] / + 20⁎⁎ 
 
+ 10⁎⁎ 
(LP) 
  
+ 25⁎⁎ + 35⁎⁎ 
     
  
Bodenheimer [17] CC      + 58 + 43        
 
 
dPACIC score: Patients Assessment of Chronic Illness Care (5 points in total). 
a    TC: total cholesterol; LP: lipid profile. 
b    This study included patients with T2 only, CVD only and T2 patients with CVD, so the data was listed in the same sequence. 
c    ACIC score: Assessment of Chronic Illness Care (11 points in total). 
e    Overall cost difference of illness care 2007-2003 per insured. 
f    DSMT reimbursement and educator salary. 
⁎⁎    Significant difference (P < 0.05). 
Table 4. Components of Chronic Care Model and limitations reported by the enrolled programs 
 
Author (publish year) Project 
name 
CCM component Limitations 
  
HSHO CIS DS DSD SMS CORP Study 
design 
issue 
Data 
contamina
tion 
Intervention 
issues 
Patient 
issue 
Professional 
provider 
issue 
Data 
constraints 
Measurement 
issue 
Systematic 
bias 
Follow-up 
issue 
Money 
concer
n 
Page (2015) [44] FHQC ● ● 
 
● ● ● ‡ 
 
‡ ‡ 
      
Ku (2015) [31] FiLDCare ● ● ● ● ● ● 
      
‡ 
   
Frei (2014) [45] CARAT ● ● ● ● ● 
        
‡ ‡ 
 
Hariharan (2014) [20] DITTO ● ● ● 
 
● 
 
‡ 
  
‡ 
  
‡ ‡ 
  
Mirzaei (2013) [42] / 
 
● ● ● ● 
    
‡ 
      
Turner (2012) [39] / ● ● ● ● ● 
  
‡ ‡ 
 
‡ 
     
Lalonde (2012) [41] / ● ● 
  
● ● 
      
‡ 
   
Musacchio (2011) [49] SINERGI
A 
● ● ● ● ● 
       
‡ 
  
‡ 
Chen (2010) [38] Teamlet ● ● ● ● ● ● 
 
‡ ‡ 
 
‡ 
   
‡ 
 
Barceló (2010) [18] VIDA ● ● ● 
 
● 
  
‡ 
 
‡ 
     
‡ 
Yu (2010) [47] SJOFMRP ● ● ● ● ● ● 
  
‡ 
      
‡ 
Frølich (2010) [50] / 
  
● ● ● 
   
‡ 
   
‡ 
   
Khan (2010) [46] / ● ● ● ● ● 
   
‡ 
  
‡ 
  
‡ 
 
Sunaert (2010) [51] BE ● ● ● ● ● 
    
‡ 
 
‡ 
    
Stock (2010) [35] GP ● 
 
● ● ● ● ‡ 
  
‡ 
   
‡ 
  
Sunaert (2009) [24] BE ● ● ● ● ● 
   
‡ ‡ ‡ 
 
‡ 
 
‡ ‡ 
DiPiero (2008) [43] CIM ● ● 
  
● ● ‡ ‡ 
 
‡ 
 
‡ 
 
‡ 
  
Vargas (2007) [36] / ● 
 
● ● ● ● 
   
‡ ‡ 
    
‡ 
Caruso (2007) [40] GAP 
 
● ● ● ● 
 
‡ 
 
‡ 
       
Piatt (2006) [28] PTPROV ● ● ● ● ● ● 
  
‡ 
  
‡ 
 
‡ 
  
Siminerio (2006) [22] DSMT ● ● ● ● ● ● 
  
‡ 
   
‡ 
  
‡ 
Siminerio (2005) [21] / 
  
● ● ● 
   
‡ 
       
Stroebel (2004) [37] / 
 
● ● ● ● ● ‡ 
 
‡ ‡ 
  
‡ 
  
‡ 
MacLean (2004) [48] VIDIS 
 
● ● ● 
     
‡ 
 
‡ ‡ 
   
Bodenheimer (2002) [17] PHP 
  
● ● ● 
           
 
HPMG 
 
● ● ● ● 
           
 
CC 
 
● 
 
● ● 
           
Summary (total = 27)  18 22 23 23 26 11 6 4 12 11 4 5 9 5 4 7 
 
dPACIC score: Patients Assessment of Chronic Illness Care (5 points in total). 
a    TC: total cholesterol; LP: lipid profile. 
b    This study included patients with T2 only, CVD only and T2 patients with CVD, so the data was listed in the same sequence. 
c    ACIC score: Assessment of Chronic Illness Care (11 points in total). 
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Figure 1. Search strategy for articles on Chronic Care Models 
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Figure 2. Benefits and limitations of implementing Chronic Care Models (CCM) in primary 
care 
 
